Global Life Science Ventures
Europe, Bayern, Germany, München
Description
Global Life Science Ventures is a swiss investment fund focusing exclusively on the life sciences sector.
Investor Profile
Global Life Science Ventures has backed more than 29 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 28% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, Germany.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series A (24%)
- Series C (21%)
- Series B (21%)
- Series D (14%)
- Series E (7%)
- Series Unknown (7%)
- Debt Financing (3%)
- Series F (3%)
Country Focus
- United States (31%)
- Switzerland (21%)
- Germany (17%)
- The Netherlands (10%)
- Denmark (10%)
- Austria (3%)
- Tunisia (3%)
- France (3%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Health Diagnostics
- Genetics
- Manufacturing
- Medical Device
- Therapeutics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
